No Detail Found!

Evaluation of Some Chemokines Levels in Iraqi Patients Infected with Visceral Leishmaniasis.

Author(s)
Ali Nazar Yaseen Department of Science, College of Basic Education, Mustansiriyah University, Baghdad, Iraq
Israa Kasim Al Aubaidi Department of Biology, College of Education for pure science (Ibn al- Haitham), University of Baghdad, Baghdad, Iraq
Thikra Falih Hasan Department of Biology, College of Education for pure science (Ibn al- Haitham), University of Baghdad, Baghdad, Iraq
Abstract
Visceral leishmaniasis (VL), or kala-azar, is one of the deadliest and most disregarded of all tropical maladies. The presence of inflammatory mediators in serum could hypothetically control the disease. However, there is likewise liberation of anti-inflammatory mediators that could intervene with the control of parasite multiplication. The objective of the current work is to determine levels of some serum chemokines that incorporate granulocytes-macrophages colonies stimulating factor (GM-CSF), interferon-gamma inducible protein-10 (IP-10) and vascular endothelial growth factor (VEGF) of Iraqi patients with VL which can be considered as a biomarkers for VL infection. Sixty people were included in the present study; thirty- five of them were infected with VL while 25 uninfected people were considered as control. Patients were recognized on the premise of clinical and parasitological criteria. Sera (GM-CSF, IP-10 and VEGF) levels were determined by ELISA using a quantitative sandwich enzyme immunoassay technique. The results showed that there were no significant differences (0.05) between males and females infected with VL, while sera levels of GMCSF, IP-10, and VEGF were significantly higher in patients group than healthy subjects (P<0.01).
Publication Details
Page(s) 283-286
DOI DOI not available
Published Journal: Pakistan Journal of Biotechnology, Volume: 14, Issue: 3, Year: 2017

Request the full text from PASTIC

References
Alvar , J.I.,D.Vélez,P.Desjeux,J.Cano,J.Jannin and M.D. Boer, 2012.Leishmaniasis worldwide and global estimates of its incidence,Plos. one. 7 35671 -35683
Al-Zamel , F.,F. J.Al-Shammary,S.El-Shewemi,R.Soliman, 1996.Enhancement of leishmanicidal activity of human macrophages against Leishmania major and Leishmania donovani infection using recombinant human granulocyte macrophage colony stimulating factor,Zentralbl. Bakteriol 285 92 -105
Armah , H.B.,N.O.Wilson,B.Y.Sarfo,M.D.Powell,V.C.Bond,W.Anderson,A.A.Adjei,R.K.Gyasi,Y.Tettey,E.D.Wiredu,J.E.Tongren,V.Udhayakumar,J.K.Stiles, 2007.Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children,Malar. J 6 -
Azzurri , A.,O.Y.Sow,A.Amedei,B.Bah,S.Diallo,M.Benagiano,M.M. D'Elios , A.,Mantovani and G.,Del Prete, 2005.IFN-gammainducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection,Microbes Infect 7 1 -8
Bail , M.S. and N.J.,Diana, 2007.,Clin. Dermatol 25 203 -211
Choi , C.M.,E.A. , Lerner, 2001.Leishmaniasis as an emerging infection,J. Investig. Dermatol. Symp. Proc. 6 175 -182
Cotterell , S.E.,C.R.Engwerda,P.M.Kaye, 1999.Leishmania donovani infection initiates T cellindependent chemokine re - sponses, which are subsequently amplified in a T-cell dependent manner,Eur. J. Immunol 29 203 -214
Díaz , N.L.,O.Zerpa,F.J.Tapia, 2013.Chemokines and chemokine receptors expression in the lesions of patients with american cutaneous leishmaniasis,Mem Inst Oswaldo Cruz, Rio de Janeiro 108 446 -452
Duthie , M.S.,J.Guderian,A.Vallur,A.Bhatia,P.L.Santos,M.Todt,D.Mondal,R.Almeida,S. G.Reed, 2014.Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment,Eur J Clin Microbiol Infect Dis 33 639 -649
Falconer , K.,G.Askarieh,N.Weis,K.Hellstrand,A.Alaeus,M.Lagging, 2010.-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection,HIV. Scand. J. Infect. Dis 42 896 -901
Fallahi , P.,A.Bonatti, 2016.Leishmaniasis and IFN-gamma dependent chemokines,Clin. Ter 167 e117 -e122
Fatoux-Ardore , M.,F.Peysselona,A.Weissb,P.Bastienc,F.Pratlongc,S.Ricard-Blum, 2013.Large-scale investigation of Leishmania interaction networks with the host extracellular matrix by surface plasmon resonance imaging,Infect. Immun 82 594 -606
Gasperini , S.,M.Marchi,F.Calzetti,C.Laudanna,L.Vicentini,H.Olsen,M.Murphy,F.Liao,J.Farber,M.A.Cassatella, 1999.Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gammainducible protein-10 (IP-10) chemokines by human neutrophils,J. Immunol 162 4928 -4937
Gupta , G., S.,Bhattacharjee , S.,Bhattacharyya , P.,Bhattacharya , A.,Adhikari , A.,Mukherjee , S.B.,Majumdar and S.,Majumdar, 2009.CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response,JID 200 1300 -1310
Hailu , A.,N.Berhe,P.A.Kager, 2004.Elevated plasma levels of interferon (IFN)-g, IFN-g inducing cytokines, and IFN-g inducible CXC chemokines in visceral leishmaniasis,Am. J. Trop.Med 71 561 -567
Ibarra-Meneses , A.V.,P.Ghosh,F.Hossain,R.Chowdhury,D.Mondal,J.Alvar,J.Moreno,E.Carrillo, 2017.MIG as Biomarkers of Exposure to Leishmania spp., and of Cure in Human Visceral Leishmaniasis,Front. Cell. Infect. Microbiol 7 -
Jones , T. C., 1996.The effect of granulocyte-macrophage colony stimulating factor (rGM-CSF) on macrophage function in microbial disease,Med 13 141 -147
Kitching , A.R.,X.R.Huang,A.L.Turner,P.G.Tipping,A.R.Dunn,S.R.Holdsworth, 2002.The requirement for granulocyte-macrophage colony stimulating factor and granulocyte-colonystimulating factor in leukocyte-mediated immune glomerular injury,J. Am. Soc. Nephrol 13 350 -358
Laudanna , C.,J.Y.Kim,G.Constantin,E.Butcher, 2002.Rapid leukocyte integrin activation by chemokines,Immunol. Rev 186 37 -46
Murray , H.W.,J. S.Cervia,J.Hariprashad,A.P.Taylor,H.Hockman, 1995.Effect of granulocyte-macrophage colony-stimulating factor in experimental visceral leishmaniasis,J. Clin. Invest 95 1183 -1192
Naito , T.,H.Yokoyama,K. J.Moore,G.Dranoff,R. C.Mulligan,V. R.Kelley, 1996.Macrophage growth factors introduced into the kidney initiate renal injury,Mol. Med 2 297 -312
Oghumu , S.,C.M.Lezama-Davila,A.P.IsaacMarquez,A.R.Satoskar, 2010.Role of chemokines in regulation of immunity against leishmaniasis,Exp. Parasitol 126 389 -396
Singal , P.,P. P.Singh, 2005.Leishmania donovani amastigote componentsinduced colony-stimulating factors production,Parasitol. Int 54 9 -20
Snider , H., C.,Lezama-Davila , J.,Alexander , and R.,Abhnay, 2009.Sex hormones and modulation of immunity against Leishmaniasis,Nearo. Immuno. Modul 16 106 -133
Teixeira , M.J., C.R.,Teixeira , B.B.,Andrade , M., 2006.Barral-Netto and A. Barral, Chemokines in host-parasite interactions in leishmaniasis,Trends Parasitol 22 32 -40
Vasquez , R.E.,L. Soong,, 2006.CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice,Infect. Immun 74 6769 -6777
World Health Organization, Communicable dise-ases. WHO.C.D.S. (2003).
World HealthOrganization, 2010.Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases (, -
0

Citations

0

Downloads

61

Views